Waddell & Reed

Fund Detail

Ivy Large Cap Growth Fund
Class A Shares

Please select a fund and share class

Fund Facts
Ticker Symbol WLGAX
CUSIP 466000627
Fund Code 667
Fund Type Domestic Equity
Fund Inception 6/30/2000
Class Inception 6/30/2000
Fiscal Year End March
Dividends Paid December
Fund Assets (as of 6/30/2014) $1.5 bil
Total Equity Holdings (as of 6/30/2014) 52
Total Holdings (as of 6/30/2014) 57
Portfolio Turnover Rate (as of 3/31/2014) 50%
Lipper Category Large-Cap Growth Funds
Morningstar Category Large Growth
Benchmarks Russell 1000 Growth TR USD
Daily Prices
as of 7/23/2014
Net Asset Value (NAV) $18.75
NAV Change ($) $0.08
NAV Change (%) 0.43%
Weekly NAV Change ($) $0.12
Weekly NAV Change (%) 0.64%
Public Offering Price (POP) $19.89
Historical Prices & Distributions
Please select a date
Fund Description
Fund Objective
To seek to provide growth of capital.

Investment Approach
The Fund primarily uses a bottom-up strategy focusing on companies that we feel have dominant market positions and established competitive advantages. We believe that these characteristics can help to mitigate competition and lead to more sustainable revenue and earnings growth. Other factors considered are the company's brand equity, proprietary technology, economies of scale, level of inter-industry competition, interaction and bargaining power between a company, it's customers, suppliers and competitors and the threat of substitute products.
Morningstar Style Box
Source: Morningstar
Returns and Expenses

Data quoted is past performance and current performance may be lower or higher. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.

Performance at NAV does not include the effect of sales charges. Class A shares, including sales charges, reflects the maximum applicable front-end sales load.

Monthly Rates of Return Average Annual Total Returns
as of 6/30/2014
  YTD 1yr 3yr 5yr 10yr Life
Fund at NAV 4.36% 29.17% 14.55% 16.52% 8.36% 5.51%
Fund with 5.75% sales charge -1.66% 21.78% 12.31% 15.15% 7.72% 5.06%
Russell 1000 Growth TR USD 6.31% 26.92% 16.26% 19.24% 8.20% 1.62%
Lipper Large-Cap Growth Funds 4.32% 26.61% 14.53% 17.40% 7.51% N/A
Quarterly Rates of Return Average Annual Total Returns
as of 6/30/2014
  YTD 1yr 3yr 5yr 10yr Life
Fund at NAV 4.36% 29.17% 14.55% 16.52% 8.36% 5.51%
Fund with 5.75% sales charge -1.66% 21.78% 12.31% 15.15% 7.72% 5.06%
Russell 1000 Growth TR USD 6.31% 26.92% 16.26% 19.24% 8.20% 1.62%
Lipper Large-Cap Growth Funds 4.32% 26.61% 14.53% 17.40% 7.51% N/A
Expense Ratios
as of 7/31/2013
Net 1.15%
Gross 1.22%
Growth of a $10,000 Investment
through 6/30/2014
 Large Cap Growth A
 Russell 1000 Growth TR USD

Assumes an investment over 10 years or life of the share class, reinvestment of dividends and capital gains, and does not include the effect of sales charges or taxes.

Ratings and Rankings
Lipper Rankings
as of 6/30/2014
Category: Large-Cap Growth Funds
  Rank Percentile
1 Year 170 / 721 24
3 Year 296 / 607 49
5 Year 373 / 540 69
10 Year 95 / 378 26

Rankings are based on average annual total returns, but do not consider sales charges.

Morningstar Ratings
as of 6/30/2014
Category: Large Growth
Overall (out of 1500 Large Growth)
3 Year (out of 1500 Large Growth)
5 Year (out of 1316 Large Growth)
10 Year (out of 910 Large Growth)

Ratings are based on risk-adjusted returns.

Holdings
Portfolio Composition
(as a % of net assets as of 6/30/2014)
Domestic Common Stock 88.53%
Foreign Common Stock 9.83%
Cash and Cash Equivalents 1.64%
Sector Allocation
(as a % of equity holdings as of 6/30/2014)
Information Technology 28.6%
Consumer Discretionary 26.4%
Health Care 16.7%
Industrials 16.5%
Consumer Staples 4.5%
Energy 4.2%
Materials 1.8%
Telecommunication Services 1.3%
Top 10 Equity Holdings
(as a % of net assets as of 6/30/2014)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases.Gilead Sciences, Inc. 4.3%
Apple Inc., together with subsidiaries, designs, manufactures, and markets personal computers, mobile communication devices, and portable digital music and video players, as well as sells various related software, services, peripherals, and networking solutions worldwide.Apple, Inc. 4.2%
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.Biogen Idec, Inc. 4.1%
MasterCard Incorporated (MasterCard) is a global payments company that provides a economic link among financial institutions, businesses, merchants, cardholders and governments worldwide, enabling them to use electronic forms of payment instead of cash and checks.MasterCard, Inc., Class A 3.9%
Las Vegas Sands Corp. (LVSC), a global developer of destination properties (integrated resorts), features accommodations, gaming, entertainment, retail, convention and exhibition facilities, celebrity chef restaurant, etc. The company operates in 3 geographic areas: Macao, Singapore, United States.Las Vegas Sands, Inc. 3.8%
Celgene Corp. 3.6%
Canadian Pacific Railway Limited, through its subsidiaries, operates as a transcontinental railway providing freight transportation services, logistics solutions, and supply chain expertise in Canada and the United States.Canadian Pacific Railway Ltd. 3.5%
Schlumberger Limited operates as an oilfield services company in the United States and internationally.Schlumberger Ltd. 3.3%
Applied Materials, Inc. provides nanomanufacturing technology solutions for the semiconductor, flat panel display, solar, and related industries worldwide.Applied Materials, Inc. 3.3%
Visa Inc. operates retail electronic payments network worldwide. It facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.Visa, Inc., Class A 3.1%
Total Portfolio Holdings
(updated quarterly, upon availability)

View | Download (as of 3/31/2014)

Risk Factors: As with any mutual fund, the value of the Fund's shares will change, and you could lose money on your investment. An investment in the Fund is not a bank deposit and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. These and other risks are more fully described in the fund's prospectus. Not all funds or fund classes may be offered at all broker/ dealers.

Pricing: All prices and year-to-date returns are based on closing quotes unless noted, as supplied to the NASDAQ by 6:00 p.m. Eastern time.

Stylebox: The Morningstar Equity style box reveals a fund's investment strategy by displaying the fund's investment style and the market capitalization of the stocks owned.

Index Description: Russell 1000 Growth is an unmanaged index comprised of securities that represent the large cap sector of the stock market. It is not possible to invest directly in an index.

Performance results for some funds may include the effect of expense reduction arrangements. If those arrangements had not been in place, the performance results would have been lower.

Fee Waiver and/or Expense Reimbursement: Through July 31, 2014, Ivy Investment Management Company (IICO), the Fund’s investment manager, Ivy Funds Distributor, Inc. (IFDI), the Fund’s distributor, and/or Waddell & Reed Services Company, doing business as WI Services Company (WISC), the Fund’s transfer agent, have contractually agreed to reimburse sufficient management fees, 12b-1 fees and/or shareholder servicing fees to cap the expenses for the Fund’s Class A shares at 1.15%, Class B shares at 2.15%, Class C shares at 1.95%, Class E shares at 1.15%, Class I shares at 0.88%, and Class Y shares at 1.06%. Prior to that date, the expense limitation may not be terminated by IICO, IFDI, WISC or the Board of Trustees.

Morningstar Ratings: For each fund with at least a 3-year history, Morningstar calculates a risk-adjusted return measure that accounts for variation in a fund's monthly performance (including the effects of all sales charges), placing emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund and rated separately.) A fund's overall rating is derived from a weighted average of the 3-, 5- and 10-year (if applicable) rating metrics. Morningstar Rating is for the share classes specified; other classes may have different performance characteristics.

Information is subject to change and is not intended to represent any past or future investment recommendations.

Financial Advisor Opportunities
Corporate Careers